University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Qld. 4102, Australia.
Hum Mol Genet. 2013 Jun 1;22(11):2283-92. doi: 10.1093/hmg/ddt062. Epub 2013 Feb 12.
Multiple sclerosis (MS) is a common chronic inflammatory disease of the central nervous system. Susceptibility to the disease is affected by both environmental and genetic factors. Genetic factors include haplotypes in the histocompatibility complex (MHC) and over 50 non-MHC loci reported by genome-wide association studies. Amongst these, we previously reported polymorphisms in chromosome 12q13-14 with a protective effect in individuals of European descent. This locus spans 288 kb and contains 17 genes, including several candidate genes which have potentially significant pathogenic and therapeutic implications. In this study, we aimed to fine-map this locus. We have implemented a two-phase study: a variant discovery phase where we have used next-generation sequencing and two target-enrichment strategies [long-range polymerase chain reaction (PCR) and Nimblegen's solution phase hybridization capture] in pools of 25 samples; and a genotyping phase where we genotyped 712 variants in 3577 healthy controls and 3269 MS patients. This study confirmed the association (rs2069502, P = 9.9 × 10(-11), OR = 0.787) and narrowed down the locus of association to an 86.5 kb region. Although the study was unable to pinpoint the key-associated variant, we have identified a 42 (genotyped and imputed) single-nucleotide polymorphism haplotype block likely to harbour the causal variant. No evidence of association at previously reported low-frequency variants in CYP27B1 was observed. As part of the study we compared variant discovery performance using two target-enrichment strategies. We concluded that our pools enriched with Nimblegen's solution phase hybridization capture had better sensitivity to detect true variants than the pools enriched with long-range PCR, whilst specificity was better in the long-range PCR-enriched pools compared with solution phase hybridization capture enriched pools; this result has important implications for the design of future fine-mapping studies.
多发性硬化症(MS)是一种常见的中枢神经系统慢性炎症性疾病。疾病的易感性受环境和遗传因素的影响。遗传因素包括组织相容性复合体(MHC)中的单倍型和全基因组关联研究报道的 50 多个非 MHC 位点。在这些非 MHC 基因座中,我们之前报道了欧洲血统个体中具有保护作用的染色体 12q13-14 上的多态性。该基因座跨越 288kb,包含 17 个基因,包括几个候选基因,它们具有潜在的重要致病性和治疗意义。在这项研究中,我们旨在精细定位这个基因座。我们实施了两阶段研究:在变异发现阶段,我们使用了下一代测序和两种靶向富集策略[长距离聚合酶链反应(PCR)和 Nimblegen 的溶液相杂交捕获]在 25 个样本的池中共发现了 712 个变体;在基因分型阶段,我们对 3577 名健康对照者和 3269 名 MS 患者中的 712 个变体进行了基因分型。这项研究证实了该基因座的关联(rs2069502,P = 9.9×10(-11),OR = 0.787),并将关联基因座缩小到一个 86.5kb 的区域。尽管该研究未能确定关键相关变异,但我们已经确定了一个可能包含致病变异的 42 个(已基因分型和推测)单核苷酸多态性单倍型块。在 CYP27B1 之前报道的低频变异中没有观察到关联的证据。作为研究的一部分,我们比较了两种靶向富集策略的变异发现性能。我们得出的结论是,与使用长距离 PCR 富集的池相比,使用 Nimblegen 溶液相杂交捕获富集的池对真实变异的检测灵敏度更高,而与使用溶液相杂交捕获富集的池相比,使用长距离 PCR 富集的池特异性更好;这一结果对未来精细定位研究的设计具有重要意义。